Abstract Background Trimethylamine-N-Oxide (TMAO) is a proatherogenic and
prothrombotic metabolite. Our study examined the association of plasma TMAO level with …

Background and aims Recent studies have shown that trimethylamine N-oxide (TMAO) is a
risk factor for cardiovascular disease (CVD) in different clinical settings, but few studies …

The gut microbial metabolite trimethylamine N-oxide (TMAO) is increasingly regarded as a
novel risk factor for cardiovascular events and mortality. However, little is known about the …

The gut microbiota and its metabolites have become a hotspot of recent research.
Trimethylamine N-oxide (TMAO) metabolized by the gut microbiota is closely related to …

Diet has been considered a general health determinant for many years. Recent research
shows a connection between gut microbiota composition that is shaped by our diet and …

Trimethylamine-N-oxide (TMAO), a gut microbiota-produced metabolite, is accumulated in
chronic kidney disease (CKD) patients. It is well known to contribute to CKD-related …

ABSTRACT Background Trimethylamine N-oxide (TMAO), a metabolite from red meat and
fish consumption, plays a role in promoting cardiovascular events. However, data regarding …

Chronic kidney disease (CKD) patients have an increased risk of cardiovascular diseases
(CVDs). The present study aimed to investigate the gut microbiota and blood trimethylamine …

Background A gut-microbial metabolite, trimethylamine N-oxide (TMAO), has been
associated with coronary atherosclerotic burden. No previous prospective study has …

Results We observed a wide distribution of serum TMAO in our cohort, with approximately
80% of participants exhibiting TMAO concentrations≥ 56 µM and a maximum TMAO …